FARALLON CAPITAL MANAGEMENT LLC - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q3 2021$1,530,000
-89.2%
665,200
-79.3%
0.01%
-87.9%
Q2 2021$14,116,000
-39.5%
3,215,4340.0%0.06%
-50.0%
Q1 2021$23,344,0003,215,4340.12%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 5,307,751$3,101,0001.18%
TANG CAPITAL MANAGEMENT LLC 2,000,000$1,168,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$4,060,0000.08%
Artal Group S.A. 1,803,858$1,054,0000.06%
GSA CAPITAL PARTNERS LLP 616,402$360,0000.05%
RA Capital Management 3,040,885$1,776,0000.05%
Forefront Analytics, LLC 92,641$58,0000.03%
Temasek Holdings (Private) Ltd 4,319,049$2,523,1880.01%
FEDERATED HERMES, INC. 8,309,859$4,853,0000.01%
Cormorant Asset Management, LP 256,649$150,0000.01%
View complete list of ORCHARD THERAPEUTICS PLC shareholders